Cited by 135Mitochondrial Function and PathologyMetabolism and Genetic DisordersGenomics and Rare Diseases

DNM1L-related mitochondrial fission defect presenting as refractory epilepsy

Open access
Care4Rare Consortium, Vanstone, Jason R, Smith, Amanda M, McBride, Skye, Naas, Turaya, Holcik, Martin, Antoun, Ghadi, Harper, Mary-Ellen +10 more·2016·European Journal of Human Genetics

Abstract

Mitochondrial fission and fusion are dynamic processes vital to mitochondrial quality control and the maintenance of cellular respiration. In dividing mitochondria, membrane scission is accomplished by a dynamin-related GTPase, DNM1L, that oligomerizes at the site of fission and constricts in a GTP-dependent manner. There is only a single previous report of DNM1L-related clinical disease: a female neonate with encephalopathy due to defective mitochondrial and peroxisomal fission (EMPF; OMIM #614388), a lethal disorder characterized by cerebral dysgenesis, seizures, lactic acidosis, elevated very long chain fatty acids, and abnormally elongated mitochondria and peroxisomes. Here, we describe a second individual, diagnosed via whole-exome sequencing, who presented with developmental delay, refractory epilepsy, prolonged survival, and no evidence of mitochondrial or peroxisomal dysfunction on standard screening investigations in blood and urine. EEG was nonspecific, showing background slowing with frequent epileptiform activity at the frontal and central head regions. Electron microscopy of skeletal muscle showed subtle, nonspecific abnormalities of cristal organization, and confocal microscopy of patient fibroblasts showed striking hyperfusion of the mitochondrial network. A panel of further bioenergetic studies in patient fibroblasts showed no significant differences versus controls. The proband's de novo DNM1L variant, NM_012062.4:c.1085G>A; NP_036192.2:p.(Gly362Asp), falls within the middle (oligomerization) domain of DNM1L, implying a likely dominant-negative mechanism. This disorder, which presents nonspecifically and affords few diagnostic clues, can be diagnosed by means of DNM1L sequencing and/or confocal microscopy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ejhg.2015.243

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mutations in DRP1 lead to a severe neurological syndrome with microencephaly, hypotonia, alterations in brain development, and metabolism that cause neonatal lethality due to multi-system damage.

    “Mutations in DRP1 lead to a severe neurological syndrome with microencephaly, hypotonia, alterations in brain development, and metabolism that cause neonatal lethality due to multi-system damage [201–203].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Care4Rare Consortium, Vanstone, J. R., Smith, A. M., McBride, S., Naas, T., Holcik, M., Antoun, G., Harper, M.-E., Michaud, J., Sell, E., Chakraborty, P., Tetreault, M., Majewski, J., Baird, S., Boycott, K. M., Dyment, D. A., MacKenzie, A., & Lines, M. A.
Affiliations
  • University of Ottawa (CA)
  • McGill University and Génome Québec Innovation Centre (CA)
Corresponding author
Lines, Matthew A
Venue
European Journal of Human Genetics
Published
2015-11-25
Volume
24
Issue
7
Pages
1084-1088
ISSN
  • 1018-4813 (ISSN-L)
  • 1476-5438
OpenAlex
W2337169310
Cited by
135
References
18
Citations by year
2026: 5 · 2025: 10 · 2024: 9 · 2023: 5 · 2022: 11 · 2021: 25 · 2020: 17 · 2019: 14 · 2018: 17 · 2017: 12 · 2016: 10
FWCI
5.65
Type
journal article
Language
en
Open access
Locations
  • European Journal of Human Genetics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Genome Canada
  • Canadian Institutes of Health Research (MOP57810)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
Drp1, mitochondrial fission, drug-resistant epilepsy, developmental delay, de novo mutations, dominant-negative mechanism, mitochondrial hyperfusion, mitochondrial quality control, dynamin-related GTPase, mitochondrial fusion, mitochondrial encephalopathy
MeSH terms
Drug Resistant Epilepsy, Cells, Cultured, Child, Developmental Disabilities, Fibroblasts, Humans, Male, Microtubule-Associated Proteins, Mitochondria, Muscle, Syndrome, Muscle, Skeletal, Mutation, Missense, GTP Phosphohydrolases, Mitochondrial Proteins, Dynamins, Exome, Mitochondrial Dynamics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review